Literature DB >> 19494009

Intrathecal humoral responses are inversely associated with the frequency of simian immunodeficiency virus macrophage-tropic variants in the central nervous system.

Elena Ryzhova1, Pyone Aye, Tom Harvey, Wei Cao, Andrew Lackner, Francisco González-Scarano.   

Abstract

Sustained simian immunodeficiency virus (SIV) infection of the central nervous system (CNS) depends on macrophage-tropic (M-tropic) strains that are often easily neutralizable. The CNS is often thought of as an immunologically privileged site that fosters replication of M-tropic quasispecies. Yet, there are limited data addressing the intrathecal antibody response or the role of the humoral response, in general, to control M-tropic strains. We investigated the temporal course of the intrathecal fusion inhibitory activity against an M-tropic viral variant and found an inverse relationship between the magnitude of this neutralization and the prevalence of M-tropic populations. These studies suggest a role for the humoral response in the suppression of M-tropic viral species in the CNS in experimental SIV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494009      PMCID: PMC2715750          DOI: 10.1128/JVI.00235-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.

Authors:  Kenneth C Williams; William F Hickey
Journal:  Annu Rev Neurosci       Date:  2002-03-27       Impact factor: 12.449

2.  Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.

Authors:  R E Means; T Matthews; J A Hoxie; M H Malim; T Kodama; R C Desrosiers
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.

Authors:  K Mori; M Rosenzweig; R C Desrosiers
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.

Authors:  Bridget A Puffer; Stefan Pöhlmann; Aimee L Edinger; Dan Carlin; Melissa D Sanchez; Julie Reitter; Debbie D Watry; Howard S Fox; Ronald C Desrosiers; Robert W Doms
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.

Authors:  N Bannert; D Schenten; S Craig; J Sodroski
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.

Authors:  M S Orandle; K C Williams; A G MacLean; S V Westmoreland; A A Lackner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection.

Authors:  Janice E Clements; Tahar Babas; Joseph L Mankowski; K Suryanarayana; Michael Piatak; Patrick M Tarwater; Jeffrey D Lifson; M Christine Zink
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

8.  Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4.

Authors:  Elena Ryzhova; J Charles Whitbeck; Gabriela Canziani; Susan V Westmoreland; Gary H Cohen; Roselyn J Eisenberg; Andrew Lackner; Francisco González-Scarano
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples.

Authors:  Elena V Ryzhova; Peter Crino; Linda Shawver; Susan V Westmoreland; Andrew A Lackner; Francisco González-Scarano
Journal:  Virology       Date:  2002-05-25       Impact factor: 3.616

10.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  6 in total

1.  Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.

Authors:  Po-Jen Yen; Megan E Mefford; James A Hoxie; Kenneth C Williams; Ronald C Desrosiers; Dana Gabuzda
Journal:  Virology       Date:  2014-05-08       Impact factor: 3.616

2.  Multiple sclerosis typical clinical and MRI findings in a patient with HIV infection.

Authors:  Alejandra González-Duarte; Carlos Ramirez; Ricardo Pinales; Juan Sierra-Madero
Journal:  J Neurovirol       Date:  2011-10-01       Impact factor: 2.643

3.  Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.

Authors:  Jeffrey R Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

4.  Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies.

Authors:  Kathryn H Richards; Marlén Mi Aasa-Chapman; Aine McKnight; Paul R Clapham
Journal:  Retrovirology       Date:  2010-05-27       Impact factor: 4.602

5.  Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.

Authors:  Timothy W Phares; Krista D DiSano; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

Review 6.  Intrathecal humoral immunity to encephalitic RNA viruses.

Authors:  Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  Viruses       Date:  2013-02-15       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.